Condensed Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (252,000)	$ (933,000)
Adjustments to reconcile net loss to net cash provided by/(used in) operating activities:
Depreciation	85,000	87,000
Loss on disposal of fixed assets	41,000	0
Amortization of debt issuance costs	216,000	132,000
Provision for bad debts	(12,000)	(1,000)
Provision for slow moving and obsolete inventory	30,000	138,000
Share-based payment expense	30,000	79,000
Changes in:
Accounts receivable	105,000	(141,000)
Inventory	189,000	258,000
Prepaid expenses and other current assets	3,000	(13,000)
Accounts payable	(87,000)	(253,000)
Accrued expenses and other current liabilities	(191,000)	108,000
Wages payable	47,000	34,000
Net cash provided by / (used) in operating activities	204,000	(505,000)
Cash flows from investing activities:
Proceeds from sale of equipment	10,000	0
Purchase of property, plant and equipment	(21,000)	(30,000)
Patent application costs	(11,000)	(3,000)
Net cash used in investing activities	(22,000)	(33,000)
Cash flows from financing activities:
Payments on debt financing	(183,000)	(117,000)
Deferred Finance Costs	(7,000)	(130,000)
Proceeds from lines of credit	5,082,000	8,661,000
Payments on lines of credit	(5,287,000)	(7,902,000)
Net cash (used in) / provided by financing activities	(395,000)	512,000
Net decrease in cash and cash equivalents	(213,000)	(26,000)
Cash and cash equivalents - beginning of period	646,000	89,000
Cash and cash equivalents - end of period	433,000	63,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	186,000	198,000
Cash paid during period for taxes	$ 0	$ 0